Alithea Genomics
Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.
About
Technology stack
detected 2026-05-24No comments yet. Be the first to share your take.
What does Alithea Genomics do?
Alithea Genomics is a biotechnology company focused on revolutionizing drug discovery and toxicology through its proprietary RNA sequencing technology. Their platform enables industrial-scale RNA sequencing, making it more accessible and efficient for primary drug screening and toxicity assessments. This allows for faster identification of potential drug candidates and a more comprehensive understanding of their safety profiles.
How much funding has Alithea Genomics raised?
Alithea Genomics has raised a total of $11M in funding. The most recent round on record is Seed.
Where is Alithea Genomics headquartered?
Alithea Genomics is headquartered in Zurich, Switzerland.
When was Alithea Genomics founded?
Alithea Genomics was founded in 2021.
What industry does Alithea Genomics operate in?
Alithea Genomics operates in Biotechnology, Drug Discovery, Genomics, Life Sciences.
What is Alithea Genomics's current status?
Alithea Genomics's current operating status is: Inactive.